Microbiology & Infectious Diseases

A study found that 3-shogaol, a bioactive compound from ginger, boosted antibiotic activity against MRSA and showed promise as a novel antimicrobial adjuvant.

Viral hepatitis remained a major global health challenge in 2024, despite progress in HBV vaccination and HCV treatment, according to the WHO Global Hepatitis Report 2026.

A French study found nirsevimab-resistant RSV-B variants in breakthrough infant infections, underscoring the importance of continued genomic surveillance.

A Danish study found HPV-vaccinated adolescents had better STI knowledge, while vaccination was not associated with riskier sexual behaviour.

A cross-sectional study found hypertension affected nearly half of adults receiving HAART, with obesity, dyslipidaemia, elevated blood glucose, and HIV disease markers independently associated with increased risk.

A Phase III trial shows a once-daily bictegravir and lenacapavir pill could replace complex HIV treatment regimens for people with drug-resistant virus.

An enhanced tuberculosis culture assay detected asymptomatic infections missed by conventional testing, improving identification of household transmission.

A nationwide genomic study of Andes virus in Chile identified two distinct viral lineages and found no consistent genetic markers associated with severe disease or human-to-human transmission.